Literature DB >> 21567519

Cell-mediated Delivery and Targeted Erosion of Vascular Endothelial Growth Factor-Crosslinked Hydrogels.

Sung Hye Kim1, Kristi L Kiick.   

Abstract

We have previously reported a novel polymeric delivery vehicle that is assembled via interaction between heparin and the vascular endothelial growth factor (VEGF). Here, the cell-responsiveness of this hydrogel-including the delivery of VEGF in response to VEGFR-2 overexpressing PAE/KDR cells (porcine aortic endothelial cells (PAE) equipped with the transcript for the kinase insert domain receptor (KDR)), consequent erosion of the hydrogel matrix, and cellular response-are highlighted. The release of VEGF and hydrogel erosion reached 100% only in the presence of PAE/KDR. The [PEG-LMWH/VEGF] hydrogel (PEG = poly(ethylene glycol), LMWH = low molecular weight heparin) correspondingly prompted increases in VEGFR-2 phosphorylation and proliferation of PAE/KDR cells. This study proves that growth factor-crosslinked hydrogels can liberate VEGF in response to specific receptors, causing gel erosion and desired cell responses. The promise of these approaches in therapeutic applications, including targeted delivery, is suggested.
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2010        PMID: 21567519      PMCID: PMC3108855          DOI: 10.1002/marc.201000130

Source DB:  PubMed          Journal:  Macromol Rapid Commun        ISSN: 1022-1336            Impact factor:   5.734


  58 in total

1.  A reversibly antigen-responsive hydrogel.

Authors:  T Miyata; N Asami; T Uragami
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

Review 2.  Growth factor delivery for tissue engineering.

Authors:  J E Babensee; L V McIntire; A G Mikos
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

3.  Spiropyran-linked dipeptide forms supramolecular hydrogel with dual responses to light and to ligand-receptor interaction.

Authors:  Zhenjun Qiu; Haitao Yu; Jinbo Li; Yu Wang; Yan Zhang
Journal:  Chem Commun (Camb)       Date:  2009-03-30       Impact factor: 6.222

4.  Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.

Authors:  Masanori Fujita; Masayuki Ishihara; Masafumi Shimizu; Kiyohaya Obara; Shingo Nakamura; Yasuhiro Kanatani; Yuji Morimoto; Bonpei Takase; Takemi Matsui; Makoto Kikuchi; Tadaaki Maehara
Journal:  Wound Repair Regen       Date:  2007 Jan-Feb       Impact factor: 3.617

5.  Bioresponsive phosphoester hydrogels for bone tissue engineering.

Authors:  Dong-An Wang; Christopher G Williams; Fan Yang; Nicholas Cher; Hyukjin Lee; Jennifer H Elisseeff
Journal:  Tissue Eng       Date:  2005 Jan-Feb

6.  Shiga-like toxin-VEGF fusion proteins are selectively cytotoxic to endothelial cells overexpressing VEGFR-2.

Authors:  M V Backer; V G Budker; J M Backer
Journal:  J Control Release       Date:  2001-07-06       Impact factor: 9.776

7.  Refolding hydrogels self-assembled from N-(2-hydroxypropyl)methacrylamide graft copolymers by antiparallel coiled-coil formation.

Authors:  Jiyuan Yang; Chunyu Xu; Chun Wang; Jindrich Kopecek
Journal:  Biomacromolecules       Date:  2006-04       Impact factor: 6.988

8.  Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.

Authors:  Shingo Nakamura; Masayuki Ishihara; Kiyohaya Obara; Kazunori Masuoka; Takamitsu Ishizuka; Yasuhiro Kanatani; Bonpei Takase; Takemi Matsui; Hidemi Hattori; Tomoya Sato; Yutaka Kariya; Tadaaki Maehara
Journal:  J Biomed Mater Res A       Date:  2006-08       Impact factor: 4.396

9.  Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis.

Authors:  L B Jakeman; M Armanini; H S Phillips; N Ferrara
Journal:  Endocrinology       Date:  1993-08       Impact factor: 4.736

10.  Production of heparin-containing hydrogels for modulating cell responses.

Authors:  Ting Nie; Robert E Akins; Kristi L Kiick
Journal:  Acta Biomater       Date:  2008-12-24       Impact factor: 8.947

View more
  8 in total

Review 1.  Designing degradable hydrogels for orthogonal control of cell microenvironments.

Authors:  Prathamesh M Kharkar; Kristi L Kiick; April M Kloxin
Journal:  Chem Soc Rev       Date:  2013-04-22       Impact factor: 54.564

Review 2.  Adaptable hydrogel networks with reversible linkages for tissue engineering.

Authors:  Huiyuan Wang; Sarah C Heilshorn
Journal:  Adv Mater       Date:  2015-05-19       Impact factor: 30.849

Review 3.  Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials.

Authors:  Uwe Freudenberg; Yingkai Liang; Kristi L Kiick; Carsten Werner
Journal:  Adv Mater       Date:  2016-07-27       Impact factor: 30.849

Review 4.  Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications.

Authors:  Yingkai Liang; Kristi L Kiick
Journal:  Acta Biomater       Date:  2013-08-02       Impact factor: 8.947

5.  Polymeric Biomaterials: Diverse Functions Enabled by Advances in Macromolecular Chemistry.

Authors:  Yingkai Liang; Linqing Li; Rebecca A Scott; Kristi L Kiick
Journal:  Macromolecules       Date:  2017-01-06       Impact factor: 5.985

Review 6.  Translational Applications of Hydrogels.

Authors:  Santiago Correa; Abigail K Grosskopf; Hector Lopez Hernandez; Doreen Chan; Anthony C Yu; Lyndsay M Stapleton; Eric A Appel
Journal:  Chem Rev       Date:  2021-05-03       Impact factor: 60.622

Review 7.  Opportunities for multicomponent hybrid hydrogels in biomedical applications.

Authors:  Hang Kuen Lau; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2014-12-10       Impact factor: 6.988

8.  Hydrogels in Healthcare: From Static to Dynamic Material Microenvironments.

Authors:  Chelsea M Kirschner; Kristi S Anseth
Journal:  Acta Mater       Date:  2013-02-01       Impact factor: 8.203

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.